Pulmonary Hypertension
Conditions
Interventions
Idiopathic Pulmonary Arterial Hypertension:None
Pulmonary Arterial Hypertension Related to Congenital Heart Disease:None
Sponsors
Department of Cardiology, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. mean pulmonary artery pressure (mPAP) =20 mmHg; pulmonary capillary wedge pressure =15 mmHg; pulmonary vascular resistance =3 Wood units 2. patients undergo right heart catheterisation and cardiac magnetic resonance at baseline, with an interval of no more than 72 hours between the two examinations. 3. the patient had signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. patients with pulmonary hypertension WHO Group II classification, caused by left heart disease. 2. Patients with pulmonary hypertension WHO Group III classification, caused by lung disease. 3. Patients with pulmonary hypertension WHO group IV, pulmonary hypertension caused by chronic thromboembolism of the lungs. 4. Patients with pulmonary hypertension WHO Group V, in whom the cause of pulmonary hypertension is unknown or is due to multiple mechanisms. 5. Patients younger than 18 years of age. 6. Patients with pulmonary hypertension associated with congenital heart disease who have had a fall in mean pulmonary artery pressure to less than 20 mmHg following occlusion or repair surgery at baseline. 7. Patients who refused to sign the informed consent or refused to participate in the follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parameters of cardiac structure, function and tissue characteristics according to cardiac magnetic resonance;Pulmonary artery pressure and pressure in each ventricle; | — |
Countries
China
Contacts
Public ContactYucheng Chen
Department of Cardiology, West China Hospital, Sichuan University
Outcome results
None listed